553 Reduction of circulating levels of brain natriuretic peptide and C-reactive protein in patients with congestive heart failure after intermittent administration of levosimendan for 3 months

Citation:

Vassiliadis I, Thomopoulou S, Mavrogeni S, Papadopoulou E, Giamouzis G, Cokkinos DV. 553 Reduction of circulating levels of brain natriuretic peptide and C-reactive protein in patients with congestive heart failure after intermittent administration of levosimendan for 3 months. European Journal of Heart Failure Supplements. 2006;5:123–123.